Capsular has three strong patent families, at various stages of development.

​

• "Biopolymer hybrid gel-depot delivery system" WO2011003155

                        Download the file here.​

​

• "Injectable composition for delivery of a biologically active agent" WO2017177265

                       Download the file here.

​

• "Vaccine Composition" WO2019173871

                       Download the file here​.

Capsular currently has two ongoing and one completed national and international live-animal trials to validate three single-injection vaccine candidates:

 

• Cattle anti-tick vaccine –   proof-of-concept data with efficacy demonstrated (completed on Nov 2019, read and download the report here);

 

• Pig pneumonia vaccine – safety trial completed Sep 2019, commenced animal trial in Oct 2019 (ongoing trial);

​

• Pig foot and mouth disease vaccine – completed the animal safety trial Aug 2019 (ongoing trial).

Capsular's vaccine delivery platform technology was featured in the following publication, news and media: 

​

• "Developing new tick management tools",  Queensland Alliance for Agriculture and Food Innovation (QAAFI), read the article here.  

​

• "Developing new tick management tools", Meat and Livestock Australia's (MLA) Feedback magazine May/June 2019 edition, read the article here.

​

• "Tangible technologies",  Swinburne University of Technology's Research Impact Magazine. 

         Download the magazine here.  ​

         Download the article here. 

​